| 产品描述: | USP22-IN-1 (compound S02) is a potent USP22 inhibitor. USP22-IN-1 decreases the expression of FOXP3, USP22 protein and Foxp3 mRNA levels. USP22-IN-1 enhanceds anti -tumor immunity |
| 靶点: |
USP22 |
| 体内研究: |
USP22-IN-1 (20 mg/kg; i.p.; twice a day for 5 days) 增强小鼠的抗肿瘤免疫力。 Animal Model: 6-8 weeks, C57BL/6 male mice (LLC1 cells) Dosage: 20 mg/kg Administration: I.p.; twice a day for 5 days Result: Enhanced anti -tumor immunity in LLC1 -challenged mice, decreased tumor cell counts, viability, and growth. |
| 参考文献: |
1. Deyu FANG, et al. Inhibitors of ubiquitin specific peptidase 22 (usp22) and uses thereof for treating diseases and disorders. WO2022226402A1. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.955 ml |
14.775 ml |
29.55 ml |
| 5 mM |
0.591 ml |
2.955 ml |
5.91 ml |
| 10 mM |
0.295 ml |
1.477 ml |
2.955 ml |
| 50 mM |
0.059 ml |
0.295 ml |
0.591 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |